A molecular switch turns on the flame in 'nature's ...(ducts are free to leave. After anoth...)
Navigation Links
A molecular switch turns on the flame in 'nature's blowtorch'
Date:5/29/2008
ducts are free to leave.
After another substrate molecule and oxygen move into the active site, the cycle can repeat. The reorientation of a single peptide bond, an event called an "isomerization," thus acts as a molecular switch, moving the P450 between safe and active forms while protecting the P450 and its environment from accidental oxidative damage.
'/>"/>
| Contact: Laura Gardner gardner@brandeis.edu 781-736-4204 Brandeis University Source:Eurekalert |
Related biology news :
1. Scientists discover a molecular scaffold that guides connections between brain cells
2. Molecular clock could predict risk for developing breast cancer
3. Researchers discover molecular basis of a form of muscular dystrophy
4. Brown opens institute for molecular and nanoscale innovation
5. Argonne scientists develop techniques for creating molecular movies
6. Molecular basis for neurodegeneration in Ataxia telangiectasia
7. ESF conference probes waters mysterious interactions at molecular level
8. Power of molecular imaging reveals secrets of the heart
9. Computer simulations point to key molecular basis of cystic fibrosis
10. New edition of a classic molecular biology textbook from CSHL Press and Benjamin Cummings
11. Molecular Biology of the Cell celebrates 25 years of publication
Post Your Comments:
Breaking Biology News(10 mins):Breakthrough in monitoring tropical deforestation announced in Copenhagen 2Hebrew University, American researchers show 'trigger' to stem cell differentiation 2Pathological gambling may be successfully treated with medications for substance addiction 2ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference 13018 1ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference 13018 2ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference 13018 3Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 1Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 2Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 1Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 2Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 4Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 5Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 6Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 7Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 8Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 9Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 10Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 11Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 12Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 13Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 14Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 15Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 16Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 17
Other Biology News:Are sacrificial bacteria altruistic or just unlucky? 2Forests' long-term potential for carbon offsetting 2Story tips from the Department of Energy's Oak Ridge National Laboratory, April 2008 2Story tips from the Department of Energy's Oak Ridge National Laboratory, April 2008 3
Breaking Biology Technology:Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 2CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 3
[0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics[0] CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner [0] Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009[0] Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas
Other Biology Technology:Digitizing hospitals with the right tools 2Digitizing hospitals with the right tools 3Digitizing hospitals with the right tools 4
Biology Products:
Goat Anti-Proliferin (C-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.Rabbit Anti-Dideoxycytidine Polyclonal Antibody, Unconjugated from GeneTexHolten Safe 2010 Cabinet Model 0.9, with divided tabletop (230V / 50Hz) from Thermo ScientificKit for BASE20/50 units from Wave Biotech now part of GE Healthcare
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |